Reduction of blood glucose levels and suppression of G6pc expression in liver of InsrP1195L/+/HFD mice by supplementation with either CA or UDCA suggest that alterations in BAs might contribute to the development of hyperglycemia in these mice. The gene discussed is G6PC1; the disease is Hyperglycemia.